Although obtaining a specific VPS4A inhibitor may be infeasible (due to the high identity between paralogs), a pan‐VPS4 inhibitor could still be useful, because VPS4B‐deficient cancer cells are likely more sensitive to VPS4 inhibition than normal cells. This evidence concerns the gene VPS4B and cancer.